BiotechTubeBiotechTube
Home/Apogee Therapeutics/Jennifer Fox
JF

Jennifer Fox

Chief Business Officer & Chief Financial Officer, Zenas BioPharma (Board)

Apogee Therapeutics

Roles

Chief Business Officer & Chief Financial Officer, Zenas BioPharma (Board)atApogee Therapeutics
Chief Business Officer and Chief Financial OfficeratZenas BioPharma
Chief Legal OfficeratMyriad Genetics

Therapeutic Areas

DermatologyPulmonologyGastroenterologyImmunology

Apogee Therapeutics Pipeline

DrugIndicationPhase
Zumilokibart (APG777)Moderate-to-Severe Atopic DermatitisPhase 2
APG279 (Zumilokibart + APG990)Moderate-to-Severe Atopic DermatitisPhase 1
APG273 (Zumilokibart + APG333)Asthma / COPDPreclinical
APG333Respiratory & Broader I&I ConditionsPhase 1
APG808Asthma (Type 2 Allergic Diseases)Phase 1b

Leadership Team at Apogee Therapeutics

MH
Michael Henderson, MD
Chief Executive Officer
CD
Carl Dambkowski, MD
Chief Medical Officer
JP
Jane Pritchett Henderson
Chief Financial Officer
RD
Rebecca Dabora, PhD
Chief Development Officer
MB
Matt Batters, JD
Chief Legal Officer
JH
Jeff Hartness
Chief Commercial Officer
DM
Dan Mulreany
Chief Business Officer
EC
Emily Cox
SVP, Head of People
MC
Mark C. McKenna
Chairman and Chief Executive Officer, Mirador Therapeutics (Board)
LB
Lisa Bollinger, MD
Chief Executive Officer and President of Bollinger Regulatory Consulting (BRC), LLC (Board)
View full Apogee Therapeutics profile